| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002256 | American Journal of Ophthalmology | 2013 | 12 Pages |
Abstract
1Â + PRN intravitreal bevacizumab monotherapy effectively stabilized subfoveal myopic CNV. The CNV size, the baseline BCVA, and the choroidal thickness were the main prognostic factors of subfoveal myopic CNV after 1Â + PRN injection of bevacizumab.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Hyun Seung Yang, June-Gone Kim, Jee Taek Kim, Soo Geun Joe,